Severe acute interstitial nephritis induced by valsartan: A case report
Angiotensin receptor blocker (ARB) can increase serum creatinine or potassium levels in patients with renal insufficiency, renal artery stenosis, heart failure or hypovolemia, but hardly cause severe kidney injury in patients without any risk factors. A case of severe acute interstitial nephritis (A...
Gespeichert in:
Veröffentlicht in: | Medicine (Baltimore) 2019-02, Vol.98 (6), p.e14428-e14428 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e14428 |
---|---|
container_issue | 6 |
container_start_page | e14428 |
container_title | Medicine (Baltimore) |
container_volume | 98 |
creator | Chen, Tong Xu, Peng-cheng Hu, Shui-yi Yan, Tie-kun Jiang, Jian-Qing Jia, Jun-ya Wei, Li Shang, Wen-ya |
description | Angiotensin receptor blocker (ARB) can increase serum creatinine or potassium levels in patients with renal insufficiency, renal artery stenosis, heart failure or hypovolemia, but hardly cause severe kidney injury in patients without any risk factors. A case of severe acute interstitial nephritis (AIN) induced by valsartan was reported here.
A 62-year-old female with nausea for 1 month and acute deterioration of kidney function for 2 weeks was admitted. She had a history of hypertension for 5 months and had taken valsartan 40 mg daily for 4 months. Although the valsartan had been stopped for 2 weeks, the serum creatinine continuously increased after admission. Kidney biopsy demonstrated the eosinophils infiltration in interstitium.
AIN induced by valsartan.
The patient was treated with glucocorticoid.
The serum creatinine decreased gradually and got back to normal level 5 months later. Then therapy of glucocorticoid was stopped. Renal artery stenosis was excluded by computed tomography angiography (CTA).
Although valsartan-induced allergy has been reported previously, AIN was firstly recognized as a severe complication of this drug. We suggest when there is a ARB-associated continuous deterioration of kidney function for patients without renal insufficiency, renal artery stenosis, heart failure or hypovolemia, AIN should be thought of and therapy with glucocorticoid should be considered if necessary. |
doi_str_mv | 10.1097/MD.0000000000014428 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6380777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>30732201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3552-89e112a4b5a055691e1d535bb521463a273aa3f0bbffb45e0c7f57aa3f81ca5e3</originalsourceid><addsrcrecordid>eNpdUNtKw0AQXUSxtfoFguQHUveaTXwQSqtVqPigPi-bzcRE0yTsJi39e7dW62VeZji3gYPQOcFjghN5-TAb458hnNP4AA2JYFEokogfoiHGVIQykXyATpx78yImKT9GA4YloxSTIZo_wQosBNr0HQRl3YF1XdmVugpqaAvrT-fhrDeQBekmWOnKadvp-iqYBEY7CCy0je1O0VHuKTj72iP0cnvzPL0LF4_z--lkERomBA3jBAihmqdCYyGihADJBBNpKijhEdNUMq1ZjtM0z1MuABuZC7mFYmK0ADZC17vctk-XkBmoO6sr1dpyqe1GNbpUf5m6LNRrs1IRi7GU0gewXYCxjXMW8r2XYLXtVT3M1P9evevi99u957tIL-A7wbqpth2-V_0arCpAV13xmSdkQkMvTTDFMQ49ElP2AbCbhDg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Severe acute interstitial nephritis induced by valsartan: A case report</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wolters Kluwer Open Health</source><source>IngentaConnect Free/Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Chen, Tong ; Xu, Peng-cheng ; Hu, Shui-yi ; Yan, Tie-kun ; Jiang, Jian-Qing ; Jia, Jun-ya ; Wei, Li ; Shang, Wen-ya</creator><creatorcontrib>Chen, Tong ; Xu, Peng-cheng ; Hu, Shui-yi ; Yan, Tie-kun ; Jiang, Jian-Qing ; Jia, Jun-ya ; Wei, Li ; Shang, Wen-ya</creatorcontrib><description>Angiotensin receptor blocker (ARB) can increase serum creatinine or potassium levels in patients with renal insufficiency, renal artery stenosis, heart failure or hypovolemia, but hardly cause severe kidney injury in patients without any risk factors. A case of severe acute interstitial nephritis (AIN) induced by valsartan was reported here.
A 62-year-old female with nausea for 1 month and acute deterioration of kidney function for 2 weeks was admitted. She had a history of hypertension for 5 months and had taken valsartan 40 mg daily for 4 months. Although the valsartan had been stopped for 2 weeks, the serum creatinine continuously increased after admission. Kidney biopsy demonstrated the eosinophils infiltration in interstitium.
AIN induced by valsartan.
The patient was treated with glucocorticoid.
The serum creatinine decreased gradually and got back to normal level 5 months later. Then therapy of glucocorticoid was stopped. Renal artery stenosis was excluded by computed tomography angiography (CTA).
Although valsartan-induced allergy has been reported previously, AIN was firstly recognized as a severe complication of this drug. We suggest when there is a ARB-associated continuous deterioration of kidney function for patients without renal insufficiency, renal artery stenosis, heart failure or hypovolemia, AIN should be thought of and therapy with glucocorticoid should be considered if necessary.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000014428</identifier><identifier>PMID: 30732201</identifier><language>eng</language><publisher>United States: the Author(s). Published by Wolters Kluwer Health, Inc</publisher><subject>Angiotensin II Type 1 Receptor Blockers - adverse effects ; Angiotensin II Type 1 Receptor Blockers - therapeutic use ; Clinical Case Report ; Creatinine - blood ; Female ; Glucocorticoids - therapeutic use ; Humans ; Hypertension - drug therapy ; Middle Aged ; Nephritis, Interstitial - chemically induced ; Nephritis, Interstitial - drug therapy ; Valsartan - adverse effects ; Valsartan - therapeutic use</subject><ispartof>Medicine (Baltimore), 2019-02, Vol.98 (6), p.e14428-e14428</ispartof><rights>the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3552-89e112a4b5a055691e1d535bb521463a273aa3f0bbffb45e0c7f57aa3f81ca5e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380777/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380777/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,866,887,27931,27932,53798,53800</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30732201$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Tong</creatorcontrib><creatorcontrib>Xu, Peng-cheng</creatorcontrib><creatorcontrib>Hu, Shui-yi</creatorcontrib><creatorcontrib>Yan, Tie-kun</creatorcontrib><creatorcontrib>Jiang, Jian-Qing</creatorcontrib><creatorcontrib>Jia, Jun-ya</creatorcontrib><creatorcontrib>Wei, Li</creatorcontrib><creatorcontrib>Shang, Wen-ya</creatorcontrib><title>Severe acute interstitial nephritis induced by valsartan: A case report</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>Angiotensin receptor blocker (ARB) can increase serum creatinine or potassium levels in patients with renal insufficiency, renal artery stenosis, heart failure or hypovolemia, but hardly cause severe kidney injury in patients without any risk factors. A case of severe acute interstitial nephritis (AIN) induced by valsartan was reported here.
A 62-year-old female with nausea for 1 month and acute deterioration of kidney function for 2 weeks was admitted. She had a history of hypertension for 5 months and had taken valsartan 40 mg daily for 4 months. Although the valsartan had been stopped for 2 weeks, the serum creatinine continuously increased after admission. Kidney biopsy demonstrated the eosinophils infiltration in interstitium.
AIN induced by valsartan.
The patient was treated with glucocorticoid.
The serum creatinine decreased gradually and got back to normal level 5 months later. Then therapy of glucocorticoid was stopped. Renal artery stenosis was excluded by computed tomography angiography (CTA).
Although valsartan-induced allergy has been reported previously, AIN was firstly recognized as a severe complication of this drug. We suggest when there is a ARB-associated continuous deterioration of kidney function for patients without renal insufficiency, renal artery stenosis, heart failure or hypovolemia, AIN should be thought of and therapy with glucocorticoid should be considered if necessary.</description><subject>Angiotensin II Type 1 Receptor Blockers - adverse effects</subject><subject>Angiotensin II Type 1 Receptor Blockers - therapeutic use</subject><subject>Clinical Case Report</subject><subject>Creatinine - blood</subject><subject>Female</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Middle Aged</subject><subject>Nephritis, Interstitial - chemically induced</subject><subject>Nephritis, Interstitial - drug therapy</subject><subject>Valsartan - adverse effects</subject><subject>Valsartan - therapeutic use</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUNtKw0AQXUSxtfoFguQHUveaTXwQSqtVqPigPi-bzcRE0yTsJi39e7dW62VeZji3gYPQOcFjghN5-TAb458hnNP4AA2JYFEokogfoiHGVIQykXyATpx78yImKT9GA4YloxSTIZo_wQosBNr0HQRl3YF1XdmVugpqaAvrT-fhrDeQBekmWOnKadvp-iqYBEY7CCy0je1O0VHuKTj72iP0cnvzPL0LF4_z--lkERomBA3jBAihmqdCYyGihADJBBNpKijhEdNUMq1ZjtM0z1MuABuZC7mFYmK0ADZC17vctk-XkBmoO6sr1dpyqe1GNbpUf5m6LNRrs1IRi7GU0gewXYCxjXMW8r2XYLXtVT3M1P9evevi99u957tIL-A7wbqpth2-V_0arCpAV13xmSdkQkMvTTDFMQ49ElP2AbCbhDg</recordid><startdate>20190201</startdate><enddate>20190201</enddate><creator>Chen, Tong</creator><creator>Xu, Peng-cheng</creator><creator>Hu, Shui-yi</creator><creator>Yan, Tie-kun</creator><creator>Jiang, Jian-Qing</creator><creator>Jia, Jun-ya</creator><creator>Wei, Li</creator><creator>Shang, Wen-ya</creator><general>the Author(s). Published by Wolters Kluwer Health, Inc</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20190201</creationdate><title>Severe acute interstitial nephritis induced by valsartan: A case report</title><author>Chen, Tong ; Xu, Peng-cheng ; Hu, Shui-yi ; Yan, Tie-kun ; Jiang, Jian-Qing ; Jia, Jun-ya ; Wei, Li ; Shang, Wen-ya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3552-89e112a4b5a055691e1d535bb521463a273aa3f0bbffb45e0c7f57aa3f81ca5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Angiotensin II Type 1 Receptor Blockers - adverse effects</topic><topic>Angiotensin II Type 1 Receptor Blockers - therapeutic use</topic><topic>Clinical Case Report</topic><topic>Creatinine - blood</topic><topic>Female</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Middle Aged</topic><topic>Nephritis, Interstitial - chemically induced</topic><topic>Nephritis, Interstitial - drug therapy</topic><topic>Valsartan - adverse effects</topic><topic>Valsartan - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Tong</creatorcontrib><creatorcontrib>Xu, Peng-cheng</creatorcontrib><creatorcontrib>Hu, Shui-yi</creatorcontrib><creatorcontrib>Yan, Tie-kun</creatorcontrib><creatorcontrib>Jiang, Jian-Qing</creatorcontrib><creatorcontrib>Jia, Jun-ya</creatorcontrib><creatorcontrib>Wei, Li</creatorcontrib><creatorcontrib>Shang, Wen-ya</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Tong</au><au>Xu, Peng-cheng</au><au>Hu, Shui-yi</au><au>Yan, Tie-kun</au><au>Jiang, Jian-Qing</au><au>Jia, Jun-ya</au><au>Wei, Li</au><au>Shang, Wen-ya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe acute interstitial nephritis induced by valsartan: A case report</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2019-02-01</date><risdate>2019</risdate><volume>98</volume><issue>6</issue><spage>e14428</spage><epage>e14428</epage><pages>e14428-e14428</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>Angiotensin receptor blocker (ARB) can increase serum creatinine or potassium levels in patients with renal insufficiency, renal artery stenosis, heart failure or hypovolemia, but hardly cause severe kidney injury in patients without any risk factors. A case of severe acute interstitial nephritis (AIN) induced by valsartan was reported here.
A 62-year-old female with nausea for 1 month and acute deterioration of kidney function for 2 weeks was admitted. She had a history of hypertension for 5 months and had taken valsartan 40 mg daily for 4 months. Although the valsartan had been stopped for 2 weeks, the serum creatinine continuously increased after admission. Kidney biopsy demonstrated the eosinophils infiltration in interstitium.
AIN induced by valsartan.
The patient was treated with glucocorticoid.
The serum creatinine decreased gradually and got back to normal level 5 months later. Then therapy of glucocorticoid was stopped. Renal artery stenosis was excluded by computed tomography angiography (CTA).
Although valsartan-induced allergy has been reported previously, AIN was firstly recognized as a severe complication of this drug. We suggest when there is a ARB-associated continuous deterioration of kidney function for patients without renal insufficiency, renal artery stenosis, heart failure or hypovolemia, AIN should be thought of and therapy with glucocorticoid should be considered if necessary.</abstract><cop>United States</cop><pub>the Author(s). Published by Wolters Kluwer Health, Inc</pub><pmid>30732201</pmid><doi>10.1097/MD.0000000000014428</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-7974 |
ispartof | Medicine (Baltimore), 2019-02, Vol.98 (6), p.e14428-e14428 |
issn | 0025-7974 1536-5964 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6380777 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wolters Kluwer Open Health; IngentaConnect Free/Open Access Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Angiotensin II Type 1 Receptor Blockers - adverse effects Angiotensin II Type 1 Receptor Blockers - therapeutic use Clinical Case Report Creatinine - blood Female Glucocorticoids - therapeutic use Humans Hypertension - drug therapy Middle Aged Nephritis, Interstitial - chemically induced Nephritis, Interstitial - drug therapy Valsartan - adverse effects Valsartan - therapeutic use |
title | Severe acute interstitial nephritis induced by valsartan: A case report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T15%3A57%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20acute%20interstitial%20nephritis%20induced%20by%20valsartan:%20A%20case%20report&rft.jtitle=Medicine%20(Baltimore)&rft.au=Chen,%20Tong&rft.date=2019-02-01&rft.volume=98&rft.issue=6&rft.spage=e14428&rft.epage=e14428&rft.pages=e14428-e14428&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000014428&rft_dat=%3Cpubmed_cross%3E30732201%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/30732201&rfr_iscdi=true |